Manulife (Manufacturers Life Insurance)
OPRX icon

Manulife (Manufacturers Life Insurance)’s OptimizeRx OPRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,637
Closed -$250K – 3098
2022
Q1 		$250K Sell
6,637
-1,759
-21% -$77.9K ﹤0.01% 2621
2021
Q4 		$521 Sell
8,396
-126
-1% -$9.55K ﹤0.01% 2234
2021
Q3 		$729K Sell
8,522
-804
-9% -$50.4K ﹤0.01% 2029
2021
Q2 		$577K Buy
9,326
+465
+5% +$23.7K ﹤0.01% 2337
2021
Q1 		$432K Buy
8,861
+11
+0.1% +$531 ﹤0.01% 2381
2020
Q4 		$276K Buy
+8,850
New +$217K ﹤0.01% 2572

Other funds holding OPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s OPRX Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of OptimizeRx (OPRX) in Q2 2022, closing a stake of 6,637 shares — an estimated $250K sold.

Manulife (Manufacturers Life Insurance) first reported a position in OPRX in Q4 2020 and held it in 6 quarters. The position peaked at $729K in Q3 2021. 147 funds tracked by Wall St. Rank hold OPRX as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining OptimizeRx position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 6,637 OptimizeRx shares in Q2 2022, an estimated $250K.
  • Manulife (Manufacturers Life Insurance) first reported a position in OptimizeRx in Q4 2020 and held it in 6 quarters.
  • Manulife (Manufacturers Life Insurance)'s OptimizeRx position peaked at $729K in Q3 2021.
  • 147 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.